Showing 1 - 8 results of 8 for search 'Haomeng Wu', 查询时间: 0.04s Refine Results
  1. 1
    Shenling Baizhu Powder Alleviates TNBS-Induced Colitis in Rats by Improving Intestinal Epithelial Permeability and Inhibiting Inflammation Through the TLR5/MyD88/NF-κB Pathway

    Shenling Baizhu Powder Alleviates TNBS-Induced Colitis in Rats by Improving Intestinal Epithelial Permeability and Inhibiting Inflammation Through the TLR5/MyD88/NF-κB Pathway 由 Kehan Rao, Shumin Qin, Shumin Qin, Shumin Qin, Shumin Qin, Shumin Qin, Yuanming Yang, Kai Zhan, Haomeng Wu, Haomeng Wu, Haomeng Wu, Haomeng Wu, Haomeng Wu, Huan Zheng, Huan Zheng, Huan Zheng, Huan Zheng, Huan Zheng, Shaogang Huang, Shaogang Huang, Shaogang Huang, Shaogang Huang, Shaogang Huang, Shaogang Huang

    出版 2022-04-01
    获取全文
    文件
  2. 2
    Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis

    Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis 由 Yuanming Yang, Yiwei Hua, Weihuan Chen, Huan Zheng, Huan Zheng, Haomeng Wu, Haomeng Wu, Haomeng Wu, Shumin Qin, Shumin Qin, Shumin Qin, Shaogang Huang, Shaogang Huang, Shaogang Huang, Shaogang Huang, Shaogang Huang

    出版 2022-11-01
    获取全文
    文件
  3. 3
    Uncovering the Multitarget Therapeutic Mechanism of Tong-Xie-Yao-Fang on Irritable Bowel Syndrome

    Uncovering the Multitarget Therapeutic Mechanism of Tong-Xie-Yao-Fang on Irritable Bowel Syndrome 由 Xiangxue Ma, Jinke Huang, Haomeng Wu, Xia Li, Fengyun Wang, Xudong Tang

    出版 2024-01-01
    获取全文
    文件
  4. 4
    The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial

    The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial 由 Xiaohui Guo, Meiling Xuan, Huan Zheng, Shumin Qin, Haomeng Wu, Shaogang Huang, Zehuai Wen

    出版 2021-07-01
    获取全文
    文件
  5. 5
    Therapeutic peptides in the treatment of digestive inflammation: Current advances and future prospects

    Therapeutic peptides in the treatment of digestive inflammation: Current advances and future prospects 由 Liangliang He, Aijing Li, Ping Yu, Shumin Qin, Hor-Yue Tan, Denglang Zou, Haomeng Wu, Shuai Wang

    出版 2024-11-01
    获取全文
    文件
  6. 6
    Traditional Chinese medicine based on Tongjiang methodology combined with proton pump inhibitor (PPI) step-down in treating non-erosive reflux disease: a study protocol for a multicentered, randomized controlled clinical trial

    Traditional Chinese medicine based on Tongjiang methodology combined with proton pump inhibitor (PPI) step-down in treating non-erosive reflux disease: a study protocol for a multi... 由 Xia Li, Haomeng Wu, Beihua Zhang, Ting Chen, Xiaoshuang Shi, Jinxin Ma, Jiaqi Zhang, Xudong Tang, Fengyun Wang

    出版 2022-10-01
    获取全文
    文件
  7. 7
    The function of the gut microbiota–bile acid–TGR5 axis in diarrhea-predominant irritable bowel syndrome

    The function of the gut microbiota–bile acid–TGR5 axis in diarrhea-predominant irritable bowel syndrome 由 Kai Zhan, Haomeng Wu, Yongyin Xu, Kehan Rao, Huan Zheng, Shumin Qin, Yuanming Yang, Rui Jia, Weihuan Chen, Shaogang Huang

    出版 2024-03-01
    获取全文
    文件
  8. 8
    Clinical evidence of acupuncture and moxibustion for irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials

    Clinical evidence of acupuncture and moxibustion for irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials 由 Yuanming Yang, Kehan Rao, Kai Zhan, Min Shen, Huan Zheng, Shumin Qin, Haomeng Wu, Zhaoxiang Bian, Shaogang Huang, Shaogang Huang

    出版 2022-11-01
    获取全文
    文件

检索工具: